Roquefort Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ajan Reginald
Chief executive officer
UK£305.8k
Total compensation
CEO salary percentage | 90.9% |
CEO tenure | 2.1yrs |
CEO ownership | 9.0% |
Management average tenure | no data |
Board average tenure | 2.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -UK£2m |
Mar 31 2024 | n/a | n/a | -UK£2m |
Dec 31 2023 | UK£306k | UK£278k | -UK£2m |
Sep 30 2023 | n/a | n/a | -UK£2m |
Jun 30 2023 | n/a | n/a | -UK£2m |
Mar 31 2023 | n/a | n/a | -UK£2m |
Dec 31 2022 | UK£284k | UK£81k | -UK£2m |
Compensation vs Market: Ajan's total compensation ($USD406.08K) is below average for companies of similar size in the US market ($USD667.78K).
Compensation vs Earnings: Ajan's compensation has increased whilst the company is unprofitable.
CEO
Ajan Reginald (52 yo)
2.1yrs
Tenure
UK£305,800
Compensation
Mr. Trevor Ajanthan Reginald, also known as Ajan, is Co-Founder, Chief Executive Officer and Executive Director of Celixir Limited. He serves as CEO & Executive Director at Roquefort Therapeutics plc since...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 4.2yrs | UK£152.90k | 4.35% £ 268.5k | |
CEO & Executive Director | 2.1yrs | UK£305.80k | 9.03% £ 557.6k | |
Non-Executive Director | 2.5yrs | UK£26.81k | no data | |
Member of Scientific Advisory Board & Advisor to the Board | 2.7yrs | no data | no data | |
Independent Chief Medical Officer & Member of Scientific Advisory Board | 1.6yrs | no data | no data | |
Non-Executive Director | 2.1yrs | UK£24.00k | 1.16% £ 71.5k | |
Non Executive Director | 2.1yrs | UK£100.00k | 0.28% £ 17.1k | |
Member of Scientific Advisory Board | 1.6yrs | no data | no data | |
Non-Executive Director | 2.5yrs | UK£26.81k | 0.075% £ 4.6k |
2.1yrs
Average Tenure
57yo
Average Age
Experienced Board: ROQA.F's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.